Multiple sclerosis is a chronic disease of the central nervous system that affects nearly one million people in the U.S. alone. Biotech companies are working to expand therapeutic options for the disease, which is currently treated with disease-modifying drugs. Several companies, including Biogen, Immunic Therapeutics, Kyverna Therapeutics, Progentos Therapeutics, TG Therapeutics, and Zenas BioPharma, are…
Lunex Network, a newcomer in the altcoin market, is expected to experience a massive 18x rally by the end of its presale, with analysts predicting up to 1800% gains for LNEX holders. Meanwhile, Shiba Inu and Pepe investors are taking notice, with Shiba Inu’s price surging by 49.63% over the last seven days and Pepe…
Scientists have made a groundbreaking discovery on the moon’s farside, revealing signs of surprising volcanic activity near the lunar south pole. The first samples from the region, brought back by China’s Chang’e-6 spacecraft, show that the rocks formed from cooling magma relatively recently, about 2.8 billion years ago. This finding may help solve the mystery…
Solana and Binance Coin (BNB) have experienced a significant surge in value, with Solana’s market cap surpassing $100 billion and BNB’s price nearing its all-time high. Analysts predict that both cryptocurrencies could retest their all-time highs before the end of the year, driven by easing macroeconomic conditions, recent election results, and Federal Reserve rate cuts….
The biotech industry has seen a surge in the number of unicorns, with over 1,200 companies worldwide achieving valuations of over $1 billion. However, biotech unicorns are relatively rare, with only a few companies making it to the top. This article takes a closer look at 12 biotech unicorns that are making waves in the…
Donald Trump’s recent victory in the US elections has sparked renewed hope for top altcoins like Solana. The post-election rally propelled Solana to a 17% surge, overtaking BNB in the coveted top four. Analysts are predicting a rally to $1000 on the back of Solana’s growing DeFi ecosystem, fueled by Trump’s pro-crypto stance and the…
The biotech industry in Europe is experiencing significant growth, with numerous trends shaping the sector. A list of top European biotech companies that have received sizable seed funding in the past year has been compiled, highlighting companies that are directing funds towards research and development (R&D) programs in various therapeutic areas. The industry is witnessing…
The biopharma industry is witnessing a surge in investment in the immunology field, with over 10 buyouts of immunology and inflammation (I&I) drug developers this year. Several biotech companies have raised impressive funds to advance the development of their immunology-related research and development (R&D). These companies are working on innovative treatments for various diseases, including…
Elon Musk’s acquisition of X has led to a surge in false and misleading information on the platform, with the billionaire executive using it as a propaganda machine in support of Donald Trump’s presidential campaign. The Center for Countering Digital Hate found that Musk’s posts have been viewed over 2 billion times, with many of…
Wiz, a cloud security startup, turned down a $23 billion offer from Alphabet, opting to pursue a $100 billion opportunity in the cloud security space. This decision has sparked interest in the tech world, with many speculating about the future of cloud security and AI. The news also highlights the growing importance of AI in…
